FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA OKs Baxters Premix Norepinephrine

[ Price : $8.95]

FDA approves Baxters premix norepinephrine bitartrate in 5% dextrose injection, indicated for raising blood pressure in adult pati...

Guide on GMPs for Animal Cell, Tissue Products

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance for industry #253 entitled Good Manufacturing Practices for Animal C...

Donor Eligibility Guide for Animal Cell, Tissue Products

[ Price : $8.95]

Federal Register notice: FDA announces the availability of a draft guidance for industry #254 entitled Donor Eligibility for Anima...

Workshop on Orthopedic Device-Related Infections

[ Price : $8.95]

FDA announces a 12/3 virtual public workshop entitled Orthopedic Device-Related Infections II Workshop.

CGMP, Other Violations at Furley Bioextracts

[ Price : $8.95]

FDA warns Malaysias Furley Bioextracts about CGMP violations in its production of OTC drugs and manufacturing a misbranded unappro...

CGMP Violations at Laboratorio Pharma International

[ Price : $8.95]

FDA warns Honduras Laboratorio Pharma International about significant CGMP violations in its manufacturing of OTC drugs and produc...

Court Nixes FDA Compounding MOU with States

[ Price : $8.95]

The DC federal court says FDA failed to prepare a necessary regulatory flexibility analysis when it developed a Final Standard Mem...

FDA Goals for BsUFA 3 Released

[ Price : $8.95]

FDA releases the Biosimilar User Fee Act reauthorization goal letter for FY 2023-2027.

4 FDA/ECRI Material Safety Summaries Out

[ Price : $8.95]

FDA releases four medical device material safety summaries developed through a partnership with ECRI.

Cabometyx Approved for Thyroid Cancer

[ Price : $8.95]

FDA approves an Exelixis NDA for Cabometyx (cabozantinib) for treating certain adult and pediatric patients 12 years of age and ol...